首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas
【24h】

Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas

机译:266例结直肠腺瘤和癌患者中POLE和其他七个聚合酶基因的生殖系突变的频率和表型谱

获取原文
获取原文并翻译 | 示例
       

摘要

In a number of families with colorectal adenomatous polyposis or suspected Lynch syndrome/HNPCC, no germline alteration in the APC, MUTYH, or mismatch repair (MMR) genes are found. Missense mutations in the polymerase genes POLE and POLD1 have recently been identified as rare cause of multiple colorectal adenomas and carcinomas, a condition termed polymerase proofreading-associated polyposis (PPAP). The aim of the present study was to evaluate the clinical relevance and phenotypic spectrum of polymerase germline mutations. Therefore, targeted sequencing of the polymerase genes POLD1, POLD2, POLD3, POLD4, POLE, POLE2, POLE3 and POLE4 was performed in 266 unrelated patients with polyposis or fulfilled Amsterdam criteria. The POLE mutation c.1270C>G;p.Leu424Val was detected in four unrelated patients. The mutation was present in 1.5% (4/266) of all patients, 4% (3/77) of all familial cases and 7% (2/30) of familial polyposis cases. The colorectal phenotype in 14 affected individuals ranged from typical adenomatous polyposis to a HNPCC phenotype, with high intrafamilial variability. Multiple colorectal carcinomas and duodenal adenomas were common, and one case of duodenal carcinoma was reported. Additionally, various extraintestinal lesions were evident. Nine further putative pathogenic variants were identified. The most promising was c.1306C>T;p.Pro436Ser in POLE. In conclusion, a PPAP was identified in a substantial number of polyposis and familial colorectal cancer patients. Screening for polymerase proofreading mutations should therefore be considered, particularly in unexplained familial cases. The present study broadens the phenotypic spectrum of PPAP to duodenal adenomas and carcinomas, and identified novel, potentially pathogenic variants in four polymerase genes.
机译:在许多患有大肠腺瘤性息肉病或疑似林奇综合征/ HNPCC的家庭中,未发现APC,MUTYH或错配修复(MMR)基因的种系改变。聚合酶基因POLE和POLD1的错义突变最近被鉴定为多发性结直肠腺瘤和癌的罕见原因,这种情况称为聚合酶校对相关息肉病(PPAP)。本研究的目的是评估聚合酶种系突变的临床相关性和表型谱。因此,对266名无息肉病或符合阿姆斯特丹标准的无关患者进行了聚合酶基因POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLE3和POLE4的靶向测序。在四名无关患者中检测到POLE突变c.1270C> G; p.Leu424Val。突变存在于所有患者的1.5%(4/266),所有家族病例的4%(3/77)和家族息肉病病例的7%(2/30)。在14个受影响的个体中,大肠表型的范围从典型的腺瘤性息肉病到HNPCC表型,具有高的家族内变异性。多发性大肠癌和十二指肠腺瘤很常见,据报道有十二例十二指肠癌。另外,各种肠外病变是明显的。鉴定出另外九种推定的致病变体。最有前途的是POLE中的c.1306C> T; p.Pro436Ser。总之,在大量息肉病和家族性结直肠癌患者中发现了PPAP。因此,应考虑筛选聚合酶校对突变,尤其是在无法解释的家族病例中。本研究将PPAP的表型谱扩大到十二指肠腺瘤和癌,并鉴定了四个聚合酶基因中的新型潜在致病变异。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号